Neuphoria Therapeutics Inc. NEUP
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.87M | 19.44M | 22.17M | 13.65M | 14.21M |
| Total Receivables | 813.40K | 1.61M | 1.11M | 1.80K | 11.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 389.80K | 611.90K | 27.00K | 222.30K | 740.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 79.60K | 78.60K | 77.90K |
| Total Current Assets | 21.07M | 21.66M | 23.39M | 13.95M | 15.04M |
|
|
|||||
| Total Current Assets | 21.07M | 21.66M | 23.39M | 13.95M | 15.04M |
| Net Property, Plant & Equipment | -- | -- | -- | 77.80K | 105.40K |
| Long-term Investments | 3.50M | 8.84M | 8.74M | 8.67M | 8.64M |
| Goodwill | 3.50M | 8.84M | 8.74M | 8.67M | 8.64M |
| Total Other Intangibles | 4.14M | 4.31M | 4.47M | 4.64M | 4.80M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 28.71M | 34.81M | 36.60M | 27.34M | 28.59M |
|
|
|||||
| Total Accounts Payable | 385.60K | 627.20K | 520.70K | 1.37M | 1.15M |
| Total Accrued Expenses | 283.50K | 492.60K | 1.67M | 3.60M | 2.88M |
| Short-term Debt | 34.30K | 34.20K | 33.50K | 33.00K | 32.80K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 85.20K | 116.30K |
| Total Finance Division Other Current Liabilities | 53.20K | 359.30K | 362.70K | 32.70K | 35.80K |
| Total Other Current Liabilities | 53.20K | 359.30K | 362.70K | 32.70K | 35.80K |
| Total Current Liabilities | 756.60K | 1.51M | 2.59M | 5.12M | 4.22M |
|
|
|||||
| Total Current Liabilities | 756.60K | 1.51M | 2.59M | 5.12M | 4.22M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 34.30K | 34.20K | 33.50K | 33.00K | 32.80K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.35M | 3.87M | 4.31M | 9.71M | 5.37M |
| Total Liabilities | 4.11M | 5.39M | 6.90M | 14.83M | 9.59M |
|
|
|||||
| Common Stock & APIC | 218.46M | 218.39M | 218.32M | 203.56M | 200.19M |
| Retained Earnings | -191.80M | -186.89M | -186.39M | -188.25M | -178.35M |
| Treasury Stock & Other | -2.06M | -2.07M | -2.23M | -2.80M | -2.85M |
| Total Common Equity | 24.60M | 29.42M | 29.70M | 12.51M | 19.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 24.60M | 29.42M | 29.70M | 12.51M | 19.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 24.60M | 29.42M | 29.70M | 12.51M | 19.00M |
|
|
|||||